G-Protein–Coupled Receptor Kinase 2–Mediated Desensitization of Adiponectin Receptor 1 in Failing Heart
- 21 April 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 131 (16) , 1392-1404
Abstract
Background—: Phosphorylative desensitization of G-protein–coupled receptors contributes significantly to post–myocardial infarction (MI) remodeling and heart failure (HF). Here, we determined whether adiponectin receptors (AdipoRs) 1 and 2 (the 7-transmembrane domain–containing receptors mediating adiponectin functions) are phosphorylatively modified and functionally impaired after MI. Methods and Results—: Post-MI HF was induced by coronary artery occlusion. Receptor phosphorylation, kinase expression, and adiponectin function were determined via in vivo, ex vivo, and in vitro models. AdipoR1 and AdipoR2 are not phosphorylated in the normal heart. However, AdipoR1 was significantly phosphorylated after MI, peaking at 7 days and remaining significantly phosphorylated thereafter. The extent of post-MI AdipoR1 phosphorylation positively correlated with the expression level of GPCR kinase (GRK) 2, the predominant GRK isoform upregulated in the failing heart. Cardiac-specific GRK2 knockout virtually abolished post-MI AdipoR1 phosphorylation, whereas virus-mediated GRK2 overexpression significantly phosphorylated AdipoR1 and blocked adiponectin metabolic-regulatory/anti-inflammatory signaling. Mass spectrometry identified serine-7, threonine-24, and threonine-53 (residues located in the n-terminal intracellular AdipoR1 region) as the GRK2 phosphorylation sites. Ex vivo experiments demonstrated that adenosine monophosphate–activated protein kinase activation and the anti–tumor necrosis factor-α effect of adiponectin were significantly inhibited in cardiomyocytes isolated from nonischemic area 7 days after MI. In vivo experiments demonstrated that acute adiponectin administration–induced cardiac GLUT4 translocation and endothelial nitric oxide synthase phosphorylation were blunted 7 days after MI. Continuous adiponectin administration beginning 7 days after MI failed to protect the heart from adverse remodeling and HF progression. Finally, cardiac-specific GRK2 knockdown restored the cardioprotective effect of adiponectin. Conclusion—: AdipoR1 is phosphorylatively modified and desensitized by GRK2 in failing cardiomyocytes, contributing to post-MI remodeling and HF progression.Keywords
This publication has 48 references indexed in Scilit:
- Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolismProceedings of the National Academy of Sciences, 2012
- Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart FailureCirculation: Heart Failure, 2012
- Essential Role of Caveolin-3 in Adiponectin Signalsome Formation and Adiponectin CardioprotectionArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- G protein-coupled receptor kinases: More than just kinases and not only for GPCRsPharmacology & Therapeutics, 2012
- Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic responseJournal of Molecular and Cellular Cardiology, 2010
- Yin-Yang Regulation of Adiponectin Signaling by APPL Isoforms in Muscle CellsJournal of Biological Chemistry, 2009
- Protective vascular and myocardial effects of adiponectinNature Clinical Practice Cardiovascular Medicine, 2008
- G‐protein‐coupled receptor phosphorylation: where, when and by whomBritish Journal of Pharmacology, 2008
- Adiponectin protects against the development of systolic dysfunction following myocardial infarctionJournal of Molecular and Cellular Cardiology, 2007
- Circulating adiponectin concentrations in patients with congestive heart failureHeart, 2006